Head-to-head · Cost-Efficiency Index
Found vs Peter MD
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Found
Insured shoppers willing to prepay 12 months upfront to reach the lowest advertised rate, who also want behavior-change coaching bundled in.
Visit FoundPeter MD
Someone who wants a single telehealth account to also cover TRT, hair loss, ED or NAD+ alongside a GLP-1 script, and who will read past the first-month price before budgeting the ongoing cost.
Visit Peter MDThe verdict
Found takes it, leading the Cost-Efficiency Index 88 to 72. A real insurance-billing pathway on both molecules — but the widely-quoted $99/mo headline requires an insurance plan AND a full year prepaid upfront; the true no-commitment rate is $199-289/mo. Peter MD still earns a C — Someone who wants a single telehealth account to also cover TRT, hair loss, ED or NAD+ alongside a GLP-1 script, and who will read past the first-month price before budgeting the ongoing cost.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the board). See how it stacks up: CoreAge Rx vs Found.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Found | Peter MD |
|---|---|---|
| Cost-Efficiency Index | 88/100 | 72/100 |
| Semaglutide / mo | $199/mo (insurance-linked) | $149/mo first-time (Level 1), $139/mo returning (Level 2) |
| Tirzepatide / mo | $199/mo (insurance-linked) | $149 first month, then $249/mo billed quarterly |
| Semaglutide / yr (modeled) | $2,388 | $1,788 |
| Tirzepatide / yr (modeled) | $2,388 | $2,988 |
| Coverage | All 50 states | Varies by treatment — excluded in several states (marketing pages list AL/ID; the affiliate program's own disclosure is wider) |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Compounded only |
| Rank on the board | #7 | #44 |
Found
88/100Where the value is
- Genuine insurance-billing pathway, unlike most cash-only compounded competitors — most members reportedly pay under $30/visit
- Nationwide
- Strong behavior-change program adds value
The tradeoffs
- The advertised '$99/mo' headline requires BOTH an insurance-linked plan AND a 12-month prepay at once — the real month-to-month rate is $199/mo (insured) or $289/mo (cash-pay), 2-3x the headline
- Coaching subscription can't be unbundled, which reduces contract flexibility
Peter MD
72/100Where the value is
- Broadest cross-category catalogue on this board under one account: TRT, ED, non-GLP-1 weight loss, GLP-1 (semaglutide/tirzepatide), men's hair loss and NAD+, plus sermorelin
- Physician-prescribed, nationwide telehealth brand operating since 2021 (Miami, FL HQ)
- Sermorelin ($585 for a 12-week supply, ~$195/mo) and NAD+ ($369 for an 8-10 week supply, ~$147-184/mo) sit in the same catalogue as the GLP-1 line for anyone consolidating multiple scripts
The tradeoffs
- Tirzepatide's $149 first-month rate steps up to $249/mo billed quarterly — the number that matters for budgeting is the renewal price, not the headline
- Semaglutide pricing depends on tier: $149/mo first-time (Level 1) vs $139/mo returning (Level 2), with different total costs ($447 vs $834) over different supply windows, so the all-in cost is not a single number
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.